Rift Valley Fever (RVF): is there a global concern on this emerging zoonotic and vector-borne disease? by Gómez-Pérez, Juanita et al.
Letter to the Editor 
 
Rift Valley Fever (RVF): is there a global concern on this emerging zoonotic and 
vector-borne disease? 
 
Juanita Gómez-Pérez,1 Valentina Londoño-Rodas,1 Carolina Hincapié-Gañan,1 Camila Saavedra-
Bustamante,1 Juan Alejandro Gaviria-Ramírez,1 Andrés Mauricio Patiño-Barbosa,2,3  
Alfonso J. Rodríguez-Morales.1,2,3,4*   
 
1School of Veterinary Medicine and Zootechnics, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, 
Colombia. 
2School of Medicine, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia. 
3Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, 
Colombia.  
4Universidad Privada Franz Tamayo/UNIFRANZ, Cochabamba, Bolivia. 
 
 
Rev Panam Enf Inf 2018; 1(1):51-52. 
  
Received 1 August 2018 - Accepted 27 August 2018. 
 
Copyright © 2018 Gómez-Pérez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted 
use, distribution, and reproduction in any medium, provided the original work is properly cited. 
 
Rift Valley Fever (RVF) is a disease caused by the 
Rift Valley Fever virus (RVFV), which is member of the 
Bunyaviridae family, Phlebovirus genus. RVF a viral 
zoonosis that primarily affects animals but can also infect 
humans. This one affects mainly domestic ruminants, 
causing large epizootics, with high rates of lethality in 
young animals and abortions in infected females [1]. The 
virus was first identified in 1931 during an investigation 
into an epidemic among sheep on a farm in the Rift 
Valley of Kenya [2]. 
This disease is currently present in Africa and in the 
Arabian Peninsula. However, different factors, such as 
globalization and climate change have facilitated the 
introduction of the virus into areas that were previously 
unrelated, through the vectors of animals or mosquitoes 
as well human cases [3], as recently occur with an 
imported case in China [4]. The consequences of its 
introduction depends on environmental factors, the 
availability of susceptible ruminants and the ability of 
local mosquitoes to transmit the virus [3]. 
In addition to animals, RVF affects humans in a 
highly variable degree. Manifestations can be in a wide 
variety of clinical signs and symptoms and compromise 
including hepatitis, retinitis [5], delayed-onset 
encephalitis, and in most cases, hemorrhagic disease.  
The global fatality rate is estimated between 0.5 and 
16% [3,6]. In the cases where the human patient develops 
with jaundice, neurological disease or hemorrhagic 
complications there is increased risk of death [7]. 
RVF is transmitted by arthropods. Vaccination helps 
to minimize the severity and incidence of outbreaks in 
the ruminant population. But the introduction of several 
vaccinated ruminants in areas free of this virus can 
trigger an outbreak and this disease can become endemic 
if there is a sustained use of live vaccines [8]. 
The presence of these outbreaks and their increase 
are associated with the “El Niño” phenomenon, which 
increase the number of mosquitoes and allow a greater 
spread of the disease are a matter of concern [3]. 
Mosquitoes are excellent vectors for RVF, mainly 
those from the genuses Culex and Aedes, which are 
vectors of a large number of viruses (dengue, 
chikungunya, Zika, yellow fever, equine encephalitis 
viruses) [9-12], with their implications for animal and 
human health.  
RVF is considered a globally significant disease that 
already affects both animals and humans. 
In the case of animals, especially cattle animals, this 
disease is characterized by a high level of abortions and 
lethality rates, the latter being 100% in neonates and 10% 
to 20% in adult animals. 
Knowledge about RVF risk areas is essential to 
prevent and control this disease. It should be taken into 
account the fact that being a disease transmitted by 
 Gómez-Pérez – Rift Valley Fever: a concerning emerging zoonotic and vector-borne pathogen 
52 
 
 
Rev Panam Enf Inf 2018; 1(1):51-52. 
mosquitoes makes the association between RVF and 
vector dynamics and its geographical distribution. 
The ecology of the vectors depends significantly on 
the environment, each mosquito species requires specific 
environmental conditions for development and survival, 
such as the availability of water for the eggs, the 
temperature for the development of the aquatic stage or 
vegetation for some species [13]. 
On 2018, WHO releases its list of priority pathogens 
that have the potential to cause a public health 
emergency, given that for them there is no, or is 
insufficient, countermeasures, such as drugs and 
vaccines that help control outbreaks. RVF was discussed 
and considered for inclusion in the priority list, given the 
fact that poses a major public health risks and further 
research and development is needed, including 
surveillance and diagnostics.  
Experts considered that given their potential to cause 
a public health emergency and the absence of efficacious 
drugs and/or vaccines, there is an urgent need for 
accelerated research and development for RVF and other 
emerging and reemerging conditions [14]. 
As WHO warned, RVF should be watched carefully 
and efforts in research should lead to a better 
understanding and evidence-based information that 
would mitigate this emerging arboviral and zoonotic 
disease. 
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